|
The Stanford University School of Medicine said on November 14 that it will use a $20 million gift to establish a research center to study cancer stem cells.
The New York-based Virginia and D.K. Ludwig Fund said that the money was part of a $120 million commitment – one of the largest gifts ever by a private foundation for cancer research – for Stanford and five other academic centers nationwide.
At Stanford the funding will be used to launch the Ludwig Center for Cancer Stem Cell Research and Medicine, and build upon the distinguished discoveries that Stanford researchers have made in this field.
The goal of the center is to identify and better understand the role of these elusive cells in common cancers and then use this knowledge to develop more effective treatments. Most of the initial grant will be used to create a permanent endowment for the Ludwig Center.
Cancer stem cells were first found in acute myeloid leukemia in 1994 and have since been found in solid tumors, including brain, breast and prostate tumors.
These stem cells have the exclusive ability to generate new cancer cells and cause the disease to spread. Thus, it appears that any treatment that leaves cancer stem cells behind will inevitably cause a patient to relapse.
The ultimate goal of cancer stem cell research at Stanford will be to develop therapies that target and destroy these critical cells.
Researchers will begin by working to identify and characterize the stem cells in various tumor types.
Stanford scientists already are collaborating in efforts to isolate stem cells in a wide range of solid tumors, including brain, ovarian, head and neck, lung, bladder, prostate, colon, breast and melanoma.
The next step will be to trace the biological pathways that enable them to self-renew and ultimately to develop and test new treatments to stop them from proliferating.
The Ludwig Fund was created by American billionaire businessman Daniel K. Ludwig, who died in 1992, leaving much of his fortune for cancer research.
Contact: http://www.Stanford.edu
...
Citation: (Article name, authors,
publication, DOI)
Article or Abstract: (link)
Contact: (link)
Start a free one-week trial
subscription to StemCellResearchNews.com to access
ALL premium
content on this Web site.
Read about research you won't hear about on the nightly news or
on Google.
Click here. (See below for information on why Premium Content is
really worth
it.)
Get the whole story: article citations, links
to further information, links to journal abstract pages, related
articles, researcher contact information, etc.
Or ...
Subscribe
to Stem Cell Lab World, Stem Cell Research News,
Stem Cell Business News for complete access PLUS biweekly
e-mail delivery of a PDF publication you can save on your
computer or print and store in a binder.
FAQ: Why do you charge to read Premium Content ($) articles?
For many years we have provided stem cell-related news and
analysis free of charge on this Web Site, supported by
advertising and subscription income. Unfortunately, in today’s
economy, advertising placements are at an all-time low. That has
forced us (and other publishers) to seek income elsewhere.
Hence, the subscription fees for premium content.
FAQ: What makes Premium Content articles worth the price?
There are seven key reasons:
1) You read about stem cell research you'll never hear about
in the general press, and you'll get the complete article, not just a snippet.
2) Important references are clickable links. (e.g., a
reference to a research institution
or researcher's lab site or more
information about a disease or disorder
are highlighted and clickable as Web links.)
3) Full citations are provided for all journal articles
so you can access the original research.
4) Links to article abstracts are provided.
5) Links to researcher e-mail addresses and lab Web sites
are provided whenever available.
6) Graphic images are provided when available.
7) Links to Related Articles in our database of more than
2,000 stem cell research articles.
Subscribe now!
Click here
to subscribe to a newsletter (including biweekly delivery of PDF
editions PLUS Web site Premium Content) or
click here to
subscribe to the Web site Premium Content only.
 |
